The subjective effects of caffeine: Bridging the gap between animal and human research

Caffeine and Behavior: Current Views & Research Trends: Current Views and Research Trends

Volumn , Issue , 2020, Pages 257-281

  Gauvin, David V ^a   Holloway, Frank A ^b  

^a Drug Enforcement Administration   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002797688     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780429271038-16     Document Type: Chapter

References (83)

1. Coren, S., Porac, C, and Ward, L. M., Sensation and Perception, 2nd ed., Academic Press, Orlando, FL, 1984.
2. Gescheider, G. A., Psychophysics: Methods, Theory, and Application, Lawrence Erlbaum Assoc, Hillsdale, NJ, 1985.
3. Matlin, M. W. and Foley, H. J., Sensation and Perception, Allyn & Bacon, Needham Heights, MA, 1992.
4. Kuffler, S. W., Nicholls, J. G., and Martin, A. R., Prom Neuron to Brain: A Cellular Approach to the Function of the Nervous System, Sinauer Assoc., Inc., Sunderland, MA, 1984.
5. Kandel, E. R., Schwartz, J. H., and Jessell, T. M., Principles of Neural Sciences, 3rd ed., Elsevier Press, New York, 1991.
6. Mackintosh, N. J., The Psychology of Animal Learning, Academic Press, London, 1974.
7. Mackintosh, N. J., Conditioning and Associative Learning, Oxford University Press, New York, 1985.
8. Gilbert, R. M. and Sutherland, N. S., Animal Discrimination Learning, Academic Press, New York, 1969.
9. Gauvin, D. V., Harland, R. D., and Holloway, F. A., Drug discrimination procedures: A method to analyze adaptation level of affective states, Drug Develop. Res., 16, 183, 1989.
10. Holloway, F. A. and Gauvin, D. V., Comments on method and theory in drug discrimination: A potpourri of problems, perplexities, and possibilities, Drug Develop. Res., 16, 195, 1989.
11. Schwartz, B., Psychology of Learning and Behavior, W.W. Norton and Company, New York, 1989.
12. Fantino, E. and Logan, C. A., The Experimental Analysis of Behavior: A Biological Perspective. W. H. Freeman and Company, San Francisco, 1979.
13. Zentall, T. R, Hogan, D. E., and Edwards, C. A., Cognitive factors in conditional learning in pigeons, in Animal Cognition, Roitblat, H. L., Bever, T. G., and Terrace, H. S., Eds., Lawrence Erlbaum Assoc., Hillsdale, NJ, 1984, 389.
14. Steven, S. S. and Galanter, E., Ratio scales and category scales from a dozen perceptual continua, J. Exp. Psychol, 54, 377, 1957.
15. Modrow, H. E. and Holloway, F. A., Caffeine discrimination in the rat, Pharmacol. Biochem. Behav., 14, 683, 1981.
16. Winter, J. C, Caffeine-induced stimulus control, Pharmacol. Biochem. Behav., 15, 157, 1981.
17. Carney, J. M, Holloway, F. A., and Modrow, H. E., Discriminative stimulus properties of methylxanthine and their metabolites in rats, Life Sci., 36, 913, 1985.
18. Modrow, H. E. and Holloway, F. A., Drug discrimination and cross generalization between two methylxanthines, Pharmacol. Biochem. Behav., 23, 425, 1985.
19. Holloway, F. A., Modrow, H. E., and Michaelis, R. C, Methylxanthine discrimination in the rat: Possible benzodiazepine and adenosine mechanisms. Pharmacol Biochem. Behav., 22, 815, 1985.
20. Gauvin, D. V., Moore, K. R., Youngblood, B. D., and Holloway, F. A., The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations, Psychopharmacology, 110, 309, 1993.
21. Holtzman, S. G., Discriminative stimulus properties of caffeine in the rat: Noradrenergic mediation. J. Pharmacol Exp. Therap., 239, 706, 1986.
22. Mumford, G. K. and Holtzman, S. G., Qualitative differences in the discriminative stimulus effects of low and high doses of caffeine in the rat, J. Pharmacol. Exp. Therap., 258, 857, 1991.
23. Holtzman, S. G., Discriminative stimulus effects of caffeine: Tolerance and cross-tolerance with methylphenidate, Life Sci., 40, 381, 1987.
24. Mariathasan, E. A. and Stolerman, I. P., Drug discrimination studies in rats with caffeine and phenylpropanolamine administered separately and as mixtures, Psychopharmacology, 109, 99, 1992.
25. Holloway, F. A., Michaelis, R. C, and Huerta, P. L., Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue, Life Sci., 36, 723, 1985.
26. Gauvin, D. V, Harland, R. D., Michaelis, R. C, and Holloway, F. A., Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue, Life Sci., 44, 67, 1989.
27. Gauvin, D. V., Criado, J. R., Moore, K. R., and Holloway, F. A., Potentiation of cocaine’s discriminative effects by caffeine: A time-effect analysis, Pharmacol Biochem. Behav., 36, 195, 1990.
28. Harland, R. D., Gauvin, D. V., Michaelis, R. C, Carney, J. M., Seale, T. W., and Holloway, F. A., Behavioral interaction between cocaine and caffeine: A drug discrimination analysis in rats, Pharmacol Biochem. Behav., 32, 1017, 1989.
29. Schechter, M. D., Potentiation of cathinone by caffeine and nikethamide, Pharmacol Biochem. Behav, 33, 299, 1989.
30. Schechter, M. D., Caffeine potentiation of apomorphine discrimination, Pharmacol Biochem. Behav, 13, 307, 1980.
31. Schechter, M. D., Caffeine potentiation of amphetamine: Implications for hy-perkinesis therapy, Pharmacol. Biochem. Behav., 6, 359, 1977.
32. Kuhn, D. M., Appel, J. B., and Greenberg, I., An analysis of some discriminative properties of d-amphetamine, Psychopharmacologia, 39, 57, 1974.
33. Jones, C. N., Howard, J. L., and McBennett, S. T., Stimulus properties of antidepressants in the rat, Psychopharmacology, 67, 111, 1980.
34. Blitzer, R. D. and Becker, R. E., Characterization of the bupropion cue in the rat: Lack of evidence for a dopaminergic mechanism, Psychopharmacology, 85, 173, 1985.
35. Browne, R. G., Anxiolytics antagonize yohimbine’s discriminative stimulus properties, Psychopharmacology, 74, 245, 1981.
36. Colpaert, F. C, Niemegeers, C. J. E., and Janssen, P. A. J., The narcotic cue: Evidence for the specificity of the stimulus properties of narcotic drugs, Arch. Intern. Pharmacodyn.Ther, 218, 268, 1975.
37. Goudie, A. J., Atkinson, J., and West, C. R., Discriminative properties of the psychostimulant s/-cathinone in a two lever operant task, Neuropharmacology, 25, 85, 1986.
38. Spealman, R. D., Discriminative stimulus effects of midazolam in squirrel monkeys: Comparison with other drugs and antagonism by Ro 15-1788, J. Pharmacol. Exp. Therap., 235, 456, 1985.
39. Gauvin, D. V. and Holloway, F. A., Cue dimensionality in the three-choice pentylenetetrazole-saline-chlordiazepoxide discrimination task, Behav. Pharmacol, 2, 417, 1991.
40. Cooper, J. R., Bloom, F. E., and Roth, R. H., The Biochemical Basis of Neuropharmacology. Oxford University Press, New York, 1991.
41. Lockhead, G. R. and King, M. C, Classifying integral stimuli, Hum. Percept. Perform., 3, 436, 1977.
42. Lockhead, G. R., Processing dimensional stimuli: a note. Psychol Rev., 79, 410, 1972.
43. Coffin, V. L. and Carney, J. M., Behavioral pharmacology of adenosine analogs, in Physiology and Pharmacology of Adenosine Derivatives, Daly, J. W., Kuroda, Y, Phillis, J. W, Shimizu, H., and Ui, M., Eds., Raven Press, New York, 1983, 267.
44. Phillis, J. W. and Wu, P. H., Roles of adenosine and adenine nucleotides in the central nervous system, in Physiology and Pharmacology of Adenosine Derivatives, Daly, J. W., Kuroda, Y, Phillis, J. W., Shimizu, H., and Ui, M., Eds., Raven Press, New York, 1983, 219.
45. Chagoya de Sanchez, V., Munoz, R. H., Suarez, J., Vidrio, S., Yanez, L., and Munoz, M. D., Day-night variations of adenosine and its metabolizing enzymes in the brain cortex of the rat - possible physiological significance for the energetic homeostasis and the sleep-wake cycle, Brain Res., 612, 115, 1993.
46. Makela, J. P. and Hilakivi, I. T, Effect of alpha-adrenoreceptor blockade on sleep and wakefulness in the rat, Pharmacol. Biochem. Behav., 24, 613, 1986.
47. Charney, D. S., Heninger, G. R., and Redmond, D. E., Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine, Life Sci., 33, 19, 1983.
48. File, S. E. and Pellow, S., Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites, Neurosci. Lett., 61, 115, 1985.
49. Johnston, A. L. and File, S. E., Yohimbine’s anxiogenic action: evidence for noradrenergic and dopaminergic sites, Pharmacol. Biochem. Behav., 32, 151, 1989.
50. Baldwin, H. A., Johnston, A. L., and File, S. E., Antagonistic effects of caffeine and yohimbine in animal tests of anxiety, Eur. J. Pharmacol, 159, 211, 1989.
51. Sethy, V. H. and Winter, J. C, Effects of yohimbine and mescaline on punished behavior in the rat, Psychopharmacology, 23, 160, 1972.
52. Winter, J. C. and Rabin, R. A., Yohimbine and serotoninergic agonists: stimulus properties and receptor binding, Drug Develop. Res., 16, 327, 1989.
53. Gauvin, D. V., Peirce, J. M., and Holloway, F. A., Perceptual masking of the chlordiazepoxide discriminative cue by both caffeine and buspirone, Pharmacol Biochem. Behav., 47, 153, 1994.
54. Arnaud, M. J., The pharmacology of caffeine, Prog. Drug Res., 31, 1987, 273.
55. Barry, H. Ill and Krimmer, E. C, Discriminable stimuli produced by alcohol and other CNS depressants, in Discriminative Stimulus Properties of Drugs, Lai, H., Ed., Plenum Press, New York, 1977, 73.
56. Little, H. J., Nutt, D. J., and Taylor, S. C, Kindling and withdrawal changes at the benzodiazepine receptor, J. Psychopharmacol., 1, 35, 1987.
57. Nutt, D. J., Benzodiazepine receptor ligands, Neurotransmissions, IV, 1988.
58. Nutt, D. J., Benzodiazepine receptor ligands, Pharmacol. Therap., 47, 233, 1990.
59. Gauvin, D. V. and Holloway, F. A., Cross-generalization between and ecologically-relevant stimulus and a pentylenetetrazole discriminative cue, Pharmacol. Biochem. Behav., 39, 521, 1991.
60. Amoore, J. E., Molecular Basis of Odor. Charles C. Thomas, Springfield, IL, 1970.
61. Shepard, R., Neural nets for generalization and classification: Comment on Staddon and Reid, Psychol. Rev., 92, 579, 1994.
62. Cain, W. S., The odoriferous environment and the application of olfactory research, in Handbook of Perception, Vol. VIA, Carterette, E. C. and Friedman, M. P., Eds., Academic Press, New York, 1978, 277.
63. Gesteland, R. C, The neural code: integrative neural mechanisms, inHandbook of Perception, Vol. VIA, Carterette, E. C. and Friedman, M. P., Eds., Academic Press, New York, 1978, 259.
64. Beidler, L. M., Biophysics and chemistry of taste. inHandbook of Perception, Vol. VIA, Carterette, E. C. and Friedman, M. P., Eds., Academic Press, New York, 1978, 21.
65. McBurney, D. H., Psychological dimensions and perceptual analyses of taste, in Handbook of Perception, Vol. VIA, Carterette, E. C. and Friedman, M. P., Eds., Academic Press, New York, 1978, 125.
66. Wright, R. H., The Sense of Smell. CRC Press, Boca Raton, FL, 1982.
67. McBurney, D. H. and Collings, V. B., Introduction to Sensation and Perception, Prentice-Hall, Inc., Englewood Cliffs, NJ, 1984.
68. Overton, D. A., State-dependent learning and drug discrimination, in Handbook of Psychopharmacology, Vol. 18, Iverson, L. L., Iversen, S. D., and Snyder, S. H., Eds., Plenum Press, New York, 1984, 59.
69. Overton, D. A., Applications and limitations of the drug discrimination method for the study of drug abuse, in Methods of Assessing the Reinforcing Properties of Abused Drugs, Bozarth, M. A., Ed., Springer-Verlag, New York, 1987, 291.
70. Helson, H., Adaptation-Level Theory: An Experimental and Systematic Approach to Behavior, Harper and Row, New York, 1966.
71. Plutchik, R., The Emotions:Facts, Theories, and a New Model, Random House, New York, 1962.
72. Revelle, W., Humphreys, M. S., Simon, L., and Gilliland, K., The interactive effects of personality, time of day, and caffeine a test of the arousal model, J. Exp. Psychol. Gen., 109, 1, 1980.
73. Leathwood, P. D. and Pollet, P., Diet-induced mood changes in normal populations, J. Psychiat. Res., 17, 147, 1983.
74. Bruce, M., Scott, N., Lader, M., and Marks, V, The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects, Br. J. Clin. Pharmacol, 22, 81, 1986.
75. Goldstein, I. B., Shapiro, D., Hui, K. K., and Yu, J. L., Blood pressure response to the “second cup of coffee, " Psychosom. Med., 52, 337, 1990.
76. Zwyghuizen-Doorenbos, A., Roehrs, T. A., Lipschutz, L., Timms, V, and Roth, T, Effects of caffeine on alertness, Psychopharmacology, 100, 36, 1990.
77. James, J. E., The influence of user status and anxious disposition on the hypertensive effects of caffeine, Intern.J. PsychophysioL, 10, 171, 1990.
78. Henry, J. P. and Stephens, P. M., Caffeine as an intensifier of stress-induced hormonal and pathophysiological changes in mice, Pharmacol. Biochem. Behav., 13, 719, 1980.
79. Boulenger, J. P., Uhde, T. W., Wolff, E. A., and Post, R. M., Increased sensitivity to caffeine in patients with panic disorders, Arch. Gen. Psychiat., 41, 1067, 1984.
80. Holtzman, S. G., Caffeine as a model drug of abuse, Trends Pharmacol. Sci., 11, 355, 1990.
81. Edelstein, E. L., A case of water dependence, Br. J. Addict., 68, 367, 1973.
82. Mello, N. K., Stimulus self-administration: some implications for the prediction of drug abuse liability, in Predicting Dependence Liability of Stimulant and Depressant Drugs, Thompson, T. and Unna, K., Eds., University Press, Baltimore, 1977, 243.
83. Kaul, B. and Davidow, B., Drug abuse patterns of patients on methadone treatment in New York City, Am. J. Drug Alcoh. Abuse, 8, 17, 1981.